About Olympus Corp. 
Olympus Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
206,512 Million
(Quarterly Results - Jun 2025)
Net Profit:
8,991 Million
Pharmaceuticals & Biotechnology
JPY 2,132,426 Million (Large Cap)
12.00
NA
0.03%
0.04
16.70%
2.91






